Biogen Names Michel Vounatsos Chief Executive Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
Biogen (BIIB) New CEO Doesn't Change Outlook at Baird
December 20, 2016 12:21 PM ESTBaird analsyt Brian Skorney has no change in his outlook to his Biogen (NASDAQ: BIIB) outlook after the company announced a new CEO. The analsyt also notes his strong commercial background.
Skorney commented, "After a months-long CEO search, Biogen announced appointment of Michel... More
Mizuho Analyst Trys to Explain Why Biogen (BIIB) is Up Despite New CEO News
December 20, 2016 10:59 AM ESTMizuho analyst Salim Syed weighed in on Biogen (NASDAQ: BIIB) with shares trading up on the new CEO announcement; contrary to the view of many on the Street that shares would trade down on the notion M&A would be taken... More
New Biogen (BIIB) CEO Doesn't Take M&A Off the Table - BMO
December 19, 2016 5:42 PM ESTBMO Capital analyst M. Ian Somaiya weighed in on Biogen (NASDAQ: BIIB) after the company named Michel Vounatsos CEO. The analyst said the appointment doesn't take M&A off the table.
Somaiya commented, "We believe Michel Vounatsos brings significant commercial... More
